Ryuichiro Nakai

722 total citations
25 papers, 606 citations indexed

About

Ryuichiro Nakai is a scholar working on Molecular Biology, Biotechnology and Pharmacology. According to data from OpenAlex, Ryuichiro Nakai has authored 25 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Biotechnology and 7 papers in Pharmacology. Recurrent topics in Ryuichiro Nakai's work include Microbial Natural Products and Biosynthesis (6 papers), Microtubule and mitosis dynamics (4 papers) and Fungal Biology and Applications (4 papers). Ryuichiro Nakai is often cited by papers focused on Microbial Natural Products and Biosynthesis (6 papers), Microtubule and mitosis dynamics (4 papers) and Fungal Biology and Applications (4 papers). Ryuichiro Nakai collaborates with scholars based in Japan, United States and Singapore. Ryuichiro Nakai's co-authors include Yoshinori Yamashita, Satoshi Nakamura, Shiro Akinaga, Akira Asai, Harumi Ogawa, Yutaka Kanda, Rikizo Aono, Kenji Wakabayashi, Yutaka Ishiguro and Koki Horikoshi and has published in prestigious journals such as Cancer Research, Antimicrobial Agents and Chemotherapy and Organic Letters.

In The Last Decade

Ryuichiro Nakai

25 papers receiving 590 citations

Peers

Ryuichiro Nakai

BIOTE

PHARM

Cuiting Lv China

Isao Uno Japan

Lianne M. McHardy Canada

Jianying Luo China

Shun‐ichi Ohba Japan

Michelle Helen Visagie South Africa

Wen‐Ying Liao Taiwan

Thierry Gras Belgium

Marilia Barreca Italy

Huailong Xu China

Cuiting Lv China

Ryuichiro Nakai

257 ×0.7

63 ×0.4

132 ×1.0

BIOTE

188 ×1.6

PHARM

58 ×0.6

Citations per year, relative to Ryuichiro Nakai Ryuichiro Nakai (= 1×) peers Cuiting Lv

Countries citing papers authored by Ryuichiro Nakai

Since Specialization

Citations

This map shows the geographic impact of Ryuichiro Nakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichiro Nakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichiro Nakai more than expected).

Fields of papers citing papers by Ryuichiro Nakai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichiro Nakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichiro Nakai. The network helps show where Ryuichiro Nakai may publish in the future.

Co-authorship network of co-authors of Ryuichiro Nakai

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichiro Nakai. A scholar is included among the top collaborators of Ryuichiro Nakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichiro Nakai. Ryuichiro Nakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takemura, Miki, Rio Nakamura, Ryuichiro Nakai, et al.. (2023). In vitro and in vivo activity of cefiderocol against Achromobacter spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates. Antimicrobial Agents and Chemotherapy. 67(12). e0034623–e0034623. 5 indexed citations

Takahashi, Yuichi, Michihiko Suzuki, Miwa Watanabe, et al.. (2021). The dual pocket binding novel tankyrase inhibitor K-476 enhances the efficacy of immune checkpoint inhibitor by attracting CD8⁺ T cells to tumors.. American Journal of Cancer Research. 11(1). 264–276. 7 indexed citations

Nakai, Ryuichiro, Rio Nakamura, Meredith Hackel, et al.. (2021). 1066. In Vitro and in Vivo Antimicrobial Activity of Cefiderocol and Comparators against Achromobacter spp. Open Forum Infectious Diseases. 8(Supplement_1). S625–S626. 2 indexed citations

Sato, Hidetaka, Miwa Watanabe, Susumu Iwamoto, et al.. (2019). The discovery and characterization of K‐563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp. Cancer Medicine. 8(3). 1157–1168. 11 indexed citations

Seike, Toshihiro, Takahiro Nakajima, Daisuke Yamaguchi, et al.. (2019). Abstract 3086: Discovery of a first-in-class TEAD inhibitor which directly inhibits YAP/TAZ-TEAD protein-protein interaction and shows a potent anti-tumor effect in malignant pleural mesothelioma. Cancer Research. 79(13_Supplement). 3086–3086. 9 indexed citations

Sumitomo, Yoshiki, Noriyuki Kasai, Kazuya Yamano, et al.. (2018). An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models.. PubMed. 8(8). 1499–1513. 35 indexed citations

Nagata, Keiko, Yutaka Kanda, Tsuguo Kubota, et al.. (2017). Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805. Translational Oncology. 10(5). 707–718. 2 indexed citations

Takahashi, Yuichi, Yasuo Watanabe, Hiroshi Ishida, et al.. (2016). The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase. Molecular Cancer Therapeutics. 15(7). 1525–1534. 41 indexed citations

Ye, Xiang S., Fan Li, Robert D. Van Horn, et al.. (2015). A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models. Molecular Cancer Therapeutics. 14(11). 2463–2472. 29 indexed citations

10.

Amishiro, Nobuyoshi, Kazuhiko Kato, Yoshihisa Ohta, et al.. (2014). Synthetic studies on mitotic kinesin Eg5 inhibitors: Synthesis and structure–activity relationships of novel 2,4,5-substituted-1,3,4-thiadiazoline derivatives. Bioorganic & Medicinal Chemistry Letters. 24(16). 3961–3963. 9 indexed citations

11.

Nakai, Ryuichiro, Shin-ichi Iida, Takeshi Takahashi, et al.. (2009). K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells. Cancer Research. 69(9). 3901–3909. 83 indexed citations

12.

Nakai, Ryuichiro, Cleo M. Salisbury, Hugh Rosen, & Benjamin F. Cravatt. (2008). Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study. Bioorganic & Medicinal Chemistry. 17(3). 1101–1108. 18 indexed citations

13.

Nakai, Ryuichiro, Hiroyuki Ishida, Akira Asai, et al.. (2006). Telomerase Inhibitors Identified by a Forward Chemical Genetics Approach Using a Yeast Strain with Shortened Telomere Length. Chemistry & Biology. 13(2). 183–190. 35 indexed citations

14.

Onodera, Hideyuki, et al.. (2004). MPC1001 and Its Analogues: New Antitumor Agents from the Fungus Cladorrhinum Species. Organic Letters. 6(22). 4101–4104. 48 indexed citations

15.

Nakai, Ryuichiro, et al.. (2004). MPC1001, a New Antitumor Antibiotic Produced by Cladorrhinum sp.. The Journal of Antibiotics. 57(8). 532–534. 27 indexed citations

16.

Agatsuma, Tsutomu, Tsutomu Akama, Shinji Nara, et al.. (2002). UCS1025A and B, New Antitumor Antibiotics from the Fungus Acremonium Species. Organic Letters. 4(25). 4387–4390. 71 indexed citations

17.

Nakai, Ryuichiro, Shingo Kakita, Akira Asai, et al.. (2001). Chrolactomycin, a Novel Antitumor Antibiotic Produced by Streptomyces sp.. The Journal of Antibiotics. 54(10). 836–839. 19 indexed citations

18.

Nakai, Ryuichiro, Harumi Ogawa, Akira Asai, et al.. (2000). UCS1025A, a Novel Antibiotic Produced by Acremonium sp.. The Journal of Antibiotics. 53(3). 294–296. 52 indexed citations

19.

Takahashi, Hidenori, Ryuichiro Nakai, & Satoshi Nakamura. (2000). Purification and Partial Characterization of a Basic Xylanase Produced by ThermoalkaliphilicBacillussp. Strain TAR-1. Bioscience Biotechnology and Biochemistry. 64(4). 887–890. 11 indexed citations

20.

Nakamura, Satoshi, Ryuichiro Nakai, Kenji Wakabayashi, et al.. (1994). Thermophilic Alkaline Xylanase from Newly Isolated Alkaliphilic and ThermophilicBacillussp. Strain TAR-1. Bioscience Biotechnology and Biochemistry. 58(1). 78–81. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact